Life Sciences faces a $500B+ wave of capital projects over the next five years—a rare chance to deliver on time, on budget, and optimize long-term value. Yet value often erodes after commissioning due to fragmented data and silos. The opportunity is to close the gap between CAPEX and OPEX so systems deliver lasting value.

12:45 – 2:00 PM
Session 1: The Capital Projects Perspective
ZETA GmbH, Focaliti, Novo Nordisk Engineering

2:00 – 2:45 PM
Session 2: The Equipment Provider (OEM) Perspective
Bausch+Ströbel + Brüel & Kjær Vibro

2:45 – 3:45 PM
Session 3: The DataOps Perspective (IT-OT-ET)
Deep Digital Solutions Group, Schneider Electric, AVEVA